SSS-68

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameSSS-68
Drug Alias NameSSS68SSS-68
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitorsB-cell activating factor receptor inhibitors
TargetsTumor necrosis factor ligand superfamily member 13B-cell activating factor receptor
Therapy Area/IndicationsNephrosisLupus NephritisGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenyang Sunshine Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active Companies3sbio IncShenyang Sunshine Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNephrosisLupus NephritisGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A